|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology, Faculté de Médecine Léonard de Vinci, Bobigny, Université Paris 13, and Institut National de la Santé et de la Recherche Médicale U 426, Faculté Xavier Bichat, Université Paris 7, Paris, France; 2 Division of Allergy and Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; 3 Division of Pulmonary and Critical Care Medicine, Weill Medical College, New York, New York 10021; and 4 Cardiovascular Research Institute, University of California, San Francisco, California 94143
We investigated regulation of vascular endothelial growth factor (VEGF) expression by hypoxia in cultured and freshly isolated rat alveolar epithelial cells (AEC). In vitro, hypoxia increased VEGF mRNA and protein levels, with maximal stimulation at 0% O2 for 18 h. A similar upregulation of VEGF expression was found in alveolar epithelial type II (ATII) cells freshly isolated from rats exposed to 8% O2 for 24 h. In vitro, hypoxia-induced upregulation of VEGF mRNA was due to an increase in transcription, rather than an increase in RNA stability, inasmuch as the half-life of VEGF mRNA was unchanged. Upregulation of VEGF mRNA by hypoxia was mimicked by CoCl2 and desferrioxamine in normoxic AEC and was not prevented by inhibitors of reactive oxygen species, suggesting that hypoxic VEGF regulation involved an O2-dependent protein that requires ferrous ions but is independent of reactive oxygen species generation. In polarized ATII cells, VEGF protein was secreted at the apical and basolateral sides. Similarly, in rats, VEGF was secreted in bronchoalveolar lavage fluid. Hypoxia induced a twofold increase in VEGF protein at the apical side of ATII cells in culture and in bronchoalveolar lavage fluid. These findings suggest that release of VEGF synthesized by AEC may target not only endothelial cells but also other alveolar cells, including macrophages and epithelial cells.
reactive oxygen species; alveolar epithelial type II cells; alveolar fluid; vascular endothelial growth factor
This article has been cited by other articles:
![]() |
R. B. Schoene Illnesses at High Altitude Chest, August 1, 2008; 134(2): 402 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Lin, C.-T. Shun, S.-H. Kok, C.-C. Wang, T.-Y. Hsiao, and C.-M. Liu Hypoxia-Stimulated Vascular Endothelial Growth Factor Production in Human Nasal Polyp Fibroblasts: Effect of Epigallocatechin-3-Gallate on Hypoxia-Inducible Factor-1{alpha} Synthesis Arch Otolaryngol Head Neck Surg, May 1, 2008; 134(5): 522 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Nacak, A. Alajati, K. Leptien, C. Fulda, H. Weber, T. Miki, F. S. Czepluch, J. Waltenberger, T. Wieland, H. G. Augustin, et al. The BTB-Kelch Protein KLEIP Controls Endothelial Migration and Sprouting Angiogenesis Circ. Res., April 27, 2007; 100(8): 1155 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bouvry, C. Planes, L. Malbert-Colas, V. Escabasse, and C. Clerici Hypoxia-Induced Cytoskeleton Disruption in Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 519 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lutter and M. Spiteri Current perspectives in epithelial cell injury and repair: consequences for epithelial functions Eur. Respir. Rev., December 1, 2005; 14(97): 126 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jain and J. I. Sznajder Effects of Hypoxia on the Alveolar Epithelium Proceedings of the ATS, October 1, 2005; 2(3): 202 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Ware, R. J. Kaner, R. G. Crystal, R. Schane, N. N. Trivedi, D. McAuley, and M. A. Matthay VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema Eur. Respir. J., July 1, 2005; 26(1): 101 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Krick, B. G. Eul, J. Hanze, R. Savai, F. Grimminger, W. Seeger, and F. Rose Role of Hypoxia-Inducible Factor-1{alpha} in Hypoxia-Induced Apoptosis of Primary Alveolar Epithelial Type II Cells Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 395 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bartsch, H. Mairbaurl, M. Maggiorini, and E. R. Swenson Physiological aspects of high-altitude pulmonary edema J Appl Physiol, March 1, 2005; 98(3): 1101 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Hilbe, S Dirnhofer, F Oberwasserlechner, T Schmid, E Gunsilius, G Hilbe, E Woll, and C M Kahler CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer J. Clin. Pathol., September 1, 2004; 57(9): 965 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Raoul, B. Chailley-Heu, A.-M. Barlier-Mur, C. Delacourt, B. Maitre, and J. R. Bourbon Effects of vascular endothelial growth factor on isolated fetal alveolar type II cells Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1293 - L1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Carpenter, S. Schomberg, W. Steudel, J. Ozimek, K. Colvin, K. Stenmark, and D. D. Ivy Endothelin B Receptor Deficiency Predisposes to Pulmonary Edema Formation via Increased Lung Vascular Endothelial Cell Growth Factor Expression Circ. Res., September 5, 2003; 93(5): 456 - 463. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |